Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

April 20, 2000

Dainippon describes motility-enhancing activity of 5-HT4 receptor agonists

April 18, 2000

Isis Pharmaceuticals completes financing with Elan for HCV joint venture

April 18, 2000

Kosan Biosciences awarded SBIR grant to develop motilin receptor agonists

April 18, 2000

Maxamine plus IFN-alpha yields up to 69% complete response in HCV

April 17, 2000

Novel DELTA-lactones with utility in inflammatory conditions disclosed by Inflazyme

April 17, 2000

New anti-H. pylori agents from Byk Gulden particularly suitable for administration by the oral route

April 14, 2000

FDA grants priority review to Zelmac for IBS

April 14, 2000

Organoselenium compounds as antioxidants, cytoprotective agents presented by Oxis

April 13, 2000

Loss of hepatitis B antigen increases with increasing duration of lamivudine therapy

April 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...